Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VELVET: Pertuzumab + Trastuzumab + Vinorelbine in HER2+ Advanced Breast Cancer
NCT01565083Phase 2Completed
- Sponsor
- Roche
- Start
- Apr 2012
- Primary completion
- Oct 2015
- Modality
- Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of pertuzumab in breast cancer, sponsored by Roche. Started Apr 2012; status: completed.
02
Drugs
pertuzumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01565083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01565083.